Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So.
Portfolio Pulse from
A Wall Street analyst predicts that Moderna's stock could drop to $25. Despite its success with the Spikevax COVID-19 vaccine, which generated significant revenue and profits, the company's stock may face challenges.
February 20, 2025 | 8:45 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
A Wall Street analyst suggests Moderna's stock might fall to $25. This comes after the company's success with its COVID-19 vaccine, Spikevax, which brought in substantial revenue and profits.
The prediction of a significant drop in Moderna's stock price by a Wall Street analyst is likely to influence investor sentiment negatively. Despite the past success of Spikevax, the forecast suggests potential challenges ahead, impacting short-term stock performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100